References
- Mol BBWJ, Roberts CT, Thangaratinam S, et al. Pre-eclampsia. Lancet. 2016;387(10022):999–1011.
- Brown MA, Magee LA, Kenny L, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis and management recommendations for international practice 2018. Hypertension. 2018;72(1):24–43.
- Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165–3241.
- Butalia S, Audibert F, Côté AM, et al. Hypertension Canada. Hypertension Canada’s 2018 guidelines for the management of hypertension in pregnancy. Can J Cardiol. 2018;34(5):526–531.
- ACOG (American College of Obstetricians and Gynecologists). Practice bulletin no. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):e1–e25.
- ACOG (American College of Obstetricians and Gynecologists). Committee opinion no. 767: emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol. 2019;133(2):e174–e180.
- NICE guideline [NG133]. Hypertension in pregnancy: diagnosis and management. [ cited 2019 Sep 25]. Available from: www.nice.org.uk/guidance/ng133
- Cox AG, Marshall SA, Palmer KR, et al. Current and emerging pharmacotherapy for emergency management of preeclampsia. Expert Opin Pharmacother. 2019;20(6):701–712.
- Tamargo J, Caballero R, Delpón E. Pharmacotherapy for hypertension in pregnant patients: special considerations. Expert Opin Pharmacother. 2019;20(8):963–982.
- Miller EC. Preeclampsia and cerebrovascular disease. The maternal brain at risk. Hypertension. 2019;74(1):5–13.
- Cleary KL, Siddiq Z, Ananth CV, et al. Use of antihypertensive medications during delivery hospitalizations complicated by preeclampsia. Obstet Gynecol. 2018;131(3):441–450.
- Sridharan K, Sequeira RP. Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials. Br J Clin Pharmacol. 2018;84(9):1906–1916.
- Duley L, Meher S, Jones L. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2013;(7):CD001449.
- Easterling T, Mundle S, Bracken H, et al. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial. Lancet. 2019;394(10203):1011–1021.
- Lowe SA, Bowyer L, Lust K, et al. The SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Aust N Z J Obstet Gynaecol. 2015;55(5):e1–29.
- Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2014;6(2):CD002252.
- Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372(5):407–417.
- Magee LA, von Dadelszen P, Singer J, et al. The CHIPS randomized controlled trial (control of hypertension in pregnancy study): is severe hypertension just an elevated blood pressure? Hypertension. 2016;68(5):1153–1159.
- Duley L, Gülmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2003;(2):CD000025.
- Crowther CA, Middleton PF, Voysey M, et al. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: an individual participant data meta-analysis. PLoS Med. 2017;14(10):e1002398.
- McLaughlin K, Scholten RR, Kingdom JC, et al. Should maternal hemodynamics guide antihypertensive therapy in preeclampsia? Hypertension. 2018;71(4):550–556.
- Grandi SM, Filion KB, Yoon S, et al. Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications. Circulation. 2019;139(8):1069–1079.